PHILADELPHIA — Virginia M.-Y. Lee, PhD, and John Q. Trojanowski, MD, PhD, co-directors of the Marian S. Ware Alzheimer Drug Discovery Program at the Perelman School of Medicine at the University of Pennsylvania are co-recipients of the 2014 J. Allyn Taylor International Prize in Medicine. They are being recognized for their “tireless work to find ways to understand and treat Alzheimer’s and other neurodegenerative diseases.” Lee and Trojanowski are also professors of Pathology and Laboratory Medicine at Penn Medicine.
Western University’s Robarts Research Institute cites them as a collaborative team for the last two decades and among the 10 most cited neuroscientists in the world. Lee and Trojanowski have made major contributions to understanding the molecular basis of neurological disorders through their work uncovering major disease proteins in Alzheimer’s, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and frontotemporal degeneration.
“Their work has had an immense impact on our understanding of neurological disorders and on our ability to develop focused therapies,” said Arthur Brown, PhD, Robarts Research Institute scientist and chair of the Taylor Prize committee. “They have made an unparalleled contribution to the field of neuroscience.”
The J. Allyn Taylor International Prize in Medicine is named after the founding Chair of the Board at Robarts, and includes a cash prize of $25,000 and a medal bearing the likeness of J. Allyn Taylor. For more information, see the Taylor Prize release.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $409 million awarded in the 2014 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2014, Penn Medicine provided $771 million to benefit our community.
Department of Communications
For Patients and the General Public: